C. V. Valverde Morales

Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial

Robin L. Jones, J. Blay, K. Götze, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

J. Martín-Broto, J. Ferré, V. M. Marín, 2021, Clinical and Translational Oncology.

Results of the second interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).

U. Dirksen, N. Fenwick, S. Strauss, 2020, Journal of Clinical Oncology.

Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study

Robin L. Jones, A. Cesne, S. George, 2020, British Journal of Cancer.

Identification of response stratification factors from pooled efficacy analyses of afamitresgene autoleucel (“Afami-cel” [Formerly ADP-A2M4]) in metastatic synovial sarcoma and myxoid/round cell liposarcoma phase 1 and phase 2 trials.

J. Blay, B. V. Van Tine, S. Strauss, 2022, Journal of Clinical Oncology.

Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS)

A. Redondo, N. Hindi, A. Manzano, 2023, Cancers.